Literature DB >> 20943276

The immunological basis for treatment of stiff person syndrome.

Trygve Holmøy1, Christian Geis.   

Abstract

Antibodies against autoantigens involved in GABAergic neurotransmission are a shared feature of the different subtypes of stiff person syndrome (SPS). The autoantigens can be either presynaptic such as the smaller isoform of glutamic acid decarboxylase (GAD65), postsynaptic such as GABA-A receptor-associated protein and gephyrin, or located at the pre- and postsynaptic side such as amphiphysin. Most of these autoantigens are intracellular, and antibodies against GAD65 also occur in diabetes mellitus type 1 as well as other neurological diseases. Their pathogenic role has therefore been questioned. We here discuss the role of autoantibodies and T cells in SPS.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20943276     DOI: 10.1016/j.jneuroim.2010.09.014

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  11 in total

Review 1.  Immune mediated diseases and immune modulation in the neurocritical care unit.

Authors:  Gloria von Geldern; Thomas McPharlin; Kyra Becker
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

Review 2.  Neuronal central nervous system syndromes probably mediated by autoantibodies.

Authors:  Aude Chefdeville; Jérôme Honnorat; Christiane S Hampe; Virginie Desestret
Journal:  Eur J Neurosci       Date:  2016-03-28       Impact factor: 3.386

3.  A complex case of anti-GAD antibody-related syndrome treated with Rituximab.

Authors:  D Baroncini; F Spagnolo; L Sarro; G Comi; M A Volonte'
Journal:  Neurol Sci       Date:  2013-02-13       Impact factor: 3.307

4.  Human IgG directed against amphiphysin induces anxiety behavior in a rat model after intrathecal passive transfer.

Authors:  Christian Geis; Benedikt Grünewald; Andreas Weishaupt; Thomas Wultsch; Klaus V Toyka; Andreas Reif; Claudia Sommer
Journal:  J Neural Transm (Vienna)       Date:  2012-02-14       Impact factor: 3.575

5.  Use of subcutaneous immunoglobulin in stiff person syndrome: Case series.

Authors:  Salman Aljarallah; Scott D Newsome
Journal:  Medicine (Baltimore)       Date:  2021-03-26       Impact factor: 1.817

6.  Interactions of Human Autoantibodies with Hippocampal GABAergic Synaptic Transmission - Analyzing Antibody-Induced Effects ex vivo.

Authors:  Holger Haselmann; Luise Röpke; Christian Werner; Albrecht Kunze; Christian Geis
Journal:  Front Neurol       Date:  2015-06-11       Impact factor: 4.003

7.  Stiff-person syndrome: case series.

Authors:  Yu Jin Jung; Han G Jeong; Ryul Kim; Han-Joon Kim; Beom S Jeon
Journal:  J Mov Disord       Date:  2014-04-30

Review 8.  Clinical Spectrum of Stiff Person Syndrome: A Review of Recent Reports.

Authors:  Harini Sarva; Andres Deik; Aman Ullah; William L Severt
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2016-03-04

Review 9.  Anti-glutamic acid decarboxylase antibody positive neurological syndromes.

Authors:  Hassaan Tohid
Journal:  Neurosciences (Riyadh)       Date:  2016-07       Impact factor: 0.906

Review 10.  Evaluation of Treatment Outcomes in Patients with Stiff Person Syndrome with Rituximab vs. Standard of Care.

Authors:  Stephen Rineer; Timothy Fretwell
Journal:  Cureus       Date:  2017-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.